Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|December 1, 2005
Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumorsIgnacio Duran, Lillian L Siu, Eric X Chen, et al.
Journal of Clinical Medicine|August 4, 2015
Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational StudyAmit Bahl, Herbert Hoefeler, Ignacio Duran, et al.
Springerplus|July 22, 2014
Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational studyDiana Lüftner, Vito Lorusso, Ignacio Duran, et al.
BMC Cancer|May 17, 2018
Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutationMarta Espinosa, Juan Maria Roldán-Romero, Ignacio Duran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimusJose Pablo Maroto, Gary Hudes, Janice P Dutcher, et al.
The Oncologist|September 23, 2022
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted TherapyToni K Choueiri, Camillo Porta, Cristina Suárez, et al.
European Urology Open Science|August 2, 2021
Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysisSidra Khalid, Bassam Mohammed Basulaiman, Jeffrey Emack, et al.
Cancers|May 27, 2026
Centralized Homologous Recombination Repair Testing in Metastatic Castration-Resistant Prostate Cancer: Real-World Data from a Multicenter Spanish Precision Oncology ProgramBelén Caramelo, Pilar García-Berbel, Sofia Del Carmen, et al.
European Urology|June 3, 2014
Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysisFrancisco E Vera-Badillo, Arnoud J Templeton, Ignacio Duran, et al.
Journal of Translational Medicine|November 27, 2019
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinomaBrian W Labadie, Ping Liu, Riyue Bao, et al.
Pageof 9